Medical Xpress22d
Novel inhalable gene therapy trialed for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
USA Today1mon
Everything to know about cystic fibrosis and what causes it
The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an ...
Business Insider21d
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Ingelheim, Germany, 20 February 2025 – Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II ...
Mother Jones1mon
Project 2025 Is Gutting Medical Funding That Helped Russell Vought’s Own Kid
But some of those so-called insiders—that is, the NIH—funded research that helped scientists better understand cystic fibrosis ... which fewer than 30 people live with worldwide—NIH-led ...